Status:
COMPLETED
Prevention of Venous Thromboembolic Events After Elective Orthopaedic Surgery in Patients Treated With PRADAXA
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Venous Thromboembolism
Eligibility:
All Genders
18+ years
Brief Summary
Observational cohort study on the prevention of venous thromboembolic events after elective orthopaedic surgery for Total Knee Replacement or Total Hip Replacement iin patients treated with PRADAXA to...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Patients treated with Pradaxa undergoing surgery for Total Knee Replacement or Total Hip Replacement
- Patients 18 years of age or older at the time of recruitment
- Exclusion criteria:
- Patients presenting contraindication to prescription of Pradaxa
- Patients in whom long term Anti vitamin K treatment is indicated
Exclusion
Key Trial Info
Start Date :
August 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2012
Estimated Enrollment :
1676 Patients enrolled
Trial Details
Trial ID
NCT01139658
Start Date
August 1 2010
End Date
September 1 2012
Last Update
January 16 2014
Active Locations (53)
Enter a location and click search to find clinical trials sorted by distance.
1
Boehringer Ingelheim Investigational Site 30
Angers, France
2
Boehringer Ingelheim Investigational Site 41
Arles, France
3
Boehringer Ingelheim Investigational Site 40
Beauvais, France
4
Boehringer Ingelheim Investigational Site 2
Berck, France